Co-Diagnostics Inc. says its CoSara Diagnostics Pvt. Ltd JV

CEO Dwight Egan said the test built on "our our highly-specific, patented CoPrimer technology has been approved to differentiate between these two...

Related Keywords

Salt Lake City , Utah , United States , India , Mohal Sarabhai , Dwight Egan , World Health Organization , Central Drugs Standard Control Organization , Cosara Diagnostics Pvt , Saragene Dengue , Chikungunya Multiplex , Sara Director Mohal Sarabhai ,